CXCR4 and neoplasm: In addition, CXCL12-derived peptides, including the N-terminal amino acid sequence KPVSLSYR, were used as carriers for gene delivery to CXCR4 expressing cells demonstrating that this technique may be useful in gene therapy of tumor cells expressing CXCR4 [126,133].